Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature-Reference-Cited by-同舟云学术

Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature

Published:2002-04 Issue:2 Volume:24 Page:99-106
ISSN:0141-9854
Container-title:Clinical & Laboratory Haematology
language:en
Short-container-title:

Author:

ANDRÈS E.,KURTZ J.-E.,MALOISEL F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2257.2002.00437.x/fullpdf

Reference43 articles.

1. Andrès E. Kurtz J.E. Martin C. Kaltenbach J.E. Alt M. Weber J.C. et al Non-chemotherapy drug-induced agranulocytosis in elderly patients: the effect of granulocyte colony stimulation factor American Journal of Medicine

2. The use of haematopoietic growth factors in antithyroid-related drug-induced agranulocytosis: a report of 20 patients;Andrès;Quarterly Journal of Medicine,2001

3. Drug-associated agranulocytosis: experience at Strasbourg Teaching Hospital;Andrès;Archives of Internal Medicine,1999

4. Les facteurs de croissance hématopoiétique ont-ils une place dans le traitement des agranulocytoses médicamenteuses?;Andrès;Revue de Medicine Interne,2000

5. Agranulocytoses médicamenteuses: expérience du C.H.R.U. de Strasbourg;Andrès;Semaine des Hopitaux Paris,1998

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agranulocytosis and secondary infection related to JAK inhibitors and IL-6 receptor blockers: a disproportionality analysis using the US Food and drug administration adverse event reporting system;Frontiers in Pharmacology;2024-01-09

2. Detection of drug safety signal of drug‐induced neutropenia and agranulocytosis in all‐aged patients using electronic medical records;Pharmacoepidemiology and Drug Safety;2022-11-06

3. Allopurinol-induced Agranulocytosis: A Case Report and Review;Brown Hospital Medicine;2022-11-01

4. Evolving Role of Pharmacogenetic Biomarkers to Predict Drug-Induced Hematological Disorders;Therapeutic Drug Monitoring;2021-04

5. Hematologic Toxicity of Drug Therapy;Comprehensive Dermatologic Drug Therapy;2021